- Report
- January 2025
- 183 Pages
Global
From €4265EUR$4,500USD£3,563GBP
- Report
- May 2024
- 130 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- May 2024
- 140 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- July 2018
Global
From €4265EUR$4,500USD£3,563GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1185EUR$1,250USD£990GBP
Levocetirizine is a second-generation antihistamine used to treat allergies. It is a selective H1-receptor antagonist, meaning it blocks the action of histamine, a chemical released by the body during an allergic reaction. It is used to treat symptoms such as sneezing, runny nose, itching, and watery eyes. It is available in both prescription and over-the-counter forms.
Levocetirizine is a popular choice for treating allergies due to its effectiveness and low risk of side effects. It is generally well-tolerated and has fewer sedative effects than other antihistamines. It is also available in combination with other medications, such as decongestants, to provide relief from multiple symptoms.
Levocetirizine is marketed by several pharmaceutical companies, including Sanofi, Merck, and Mylan. It is also available in generic forms from various generic drug manufacturers. Show Less Read more